Redulen® : una novità tutta mediterranea in nutraceutica

Redulen®: a Mediterranean innovation in nutraceuticals

September 5, 2022

From Esserre Pharma research comes a new line for the management of cardio-metabolic parameters dedicated to nutrition specialists and pharmacists

Redulen®. The name comes from Latin and is the union between the verb “reducere” and the word “leniter”, an adverb that means “with sweetness”. In short, the best synthesis to express the action of a food supplement whose main objective is to improve people's well-being. Esserre Pharma launches its innovative cardio-metabolic line of food supplements with natural extracts of Mediterranean origin. Redulen® is an umbrella brand that brings together two products, one aimed at maintaining normal blood cholesterol levels and the other at modulating blood glucose levels. Redulen® Cholesterol and Redulen® Glicemia confirm the know-how acquired by Esserre Pharma in the cardiometabolic area from 2013, the year of its foundation, to today. The formula of Redulen® Cholesterol contains Brumex® (unique phytocomplex of Mediterranean bergamot), Nopalis® (exclusive extract obtained from prickly pear cladodes - Opuntia Ficus Indica), Vitamin B1 and Phytosterols. Redulen® Glicemia instead contains Lemotrin® (exclusive synergistic complex of Flavonoids) and Chromium. Both products have an international patent filed and are the result of years of careful research. “The composition of Redulen Colesterolo is based on natural extracts typical of the Mediterranean basin, which come from a short supply chain, like every product signed by Esserre Pharma. Redulen Colesterolo contains bergamot and prickly pear extract with the addition of vitamin B1 and phytosterols, highly bioavailable” – explained Costanza Riccioni, R&D Manager of Esserre Pharma - the innovative aspect lies in having associated, for the first time, these two natural extracts and, above all, in having verified that they have a synergy of action that leads to the reduction of “bad” cholesterol and other cardiovascular risk factors. Our scientific studies, conducted in collaboration with university centers, are soon to be published”. “We already knew about bergamot, we have been working on it for over eight years – continued Doctor Riccioni - These years of research have led us to the development of Brumex, our exclusive extract. We therefore looked for other Mediterranean plants that could give us innovative and effective ingredients. We have identified prickly pear (and in particular the extract of the cladodes) as the ingredient on which to invest in research and development. There has also been a great innovation in the process that led us to Redulen Glicemia: we have developed Lemotrin, a complex based on natural lemon and orange extracts rich in flavonoids and chromium”. “TheToday's consumer is looking for products from shorter , controlled and sustainable supply chains.The new Redulen lineembodies thesevalues,being itself a valid exampleof circular economy, in which thenutraceutical ingredients inside it, derivefrom recoveryof citrus by-products. A healthy lifestyle associated with a nutraceutical of Mediterranean origin, with high quality standards, can help reduce the risk factors of chronic diseases - said Amedeo Squillace, CEO Esserre Pharma - Redulen Cholesterol and Redulen Glicemia were specifically designed for nutrition specialists and pharmacists. Redulen Cholesterol and Redulen Glicemia are intended for all those who want to consciously and proactively adopt a healthy lifestyle, made up of good habits, outdoor physical exercise, adoption of a balanced diet, which together can support the prevention of health risk factors such as, precisely, alterations in cholesterol or blood sugar levels”. The Redulen® line, in the two formulations, will be distributed in pharmacies starting today and through the network of Nutra Advisors, expert consultants in the field of nutrition and nutraceuticals, it will be brought to the attention of Italian nutritionists and pharmacists. Redulen® Cholesterol is available in the 30-tablet format and its dosage requires taking one tablet per day (after dinner). Redulen® Glicemia is available in the 60-tablet format and its dosage requires taking one tablet, twice a day, after the main meals.